MIRRAGGE - Minimum Information Required for Reproducible AGGregation Experiments

Pedro M Martins1,2, Susanna Navarro3, Alexandra Silva1

  • 1Instituto de Biologia Molecular e Celular and Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.

Insights

Standardized guidelines called Minimum Information Required for Reproducible Aggregation Experiments (MIRRAGGE) were developed to improve protein aggregation studies. These guidelines enhance reproducibility and data sharing for disease mechanism research.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Biophysics

Background:

  • Protein aggregation and phase separation are crucial in understanding human diseases.
  • Current research lacks standardized methods, hindering reproducibility and data interpretation.
  • Existing data is valuable for drug screening and developing aggregation prediction algorithms.

Purpose of the Study:

  • To establish standardized guidelines for reproducible protein aggregation experiments.
  • To address the need for detailed methods and aggregate descriptions.
  • To facilitate data sharing and improve the reliability of aggregation studies.

Main Methods:

  • Developed the Minimum Information Required for Reproducible Aggregation Experiments (MIRRAGGE) guidelines.
  • Incorporated first-principles and existing literature on protein self-assembly.
  • Focused on essential determinants of experimental reproducibility.

Main Results:

  • The MIRRAGGE guidelines provide a comprehensive framework for experimental design and reporting.
  • A MIRRAGGE table template is available to guide researchers.
  • The guidelines aim to improve the consistency and comparability of aggregation assay results.

Conclusions:

  • Standardized reporting through MIRRAGGE enhances the reproducibility of protein aggregation experiments.
  • These guidelines facilitate accurate data deposition into databases.
  • MIRRAGGE supports translational research, drug discovery, and the development of predictive models for aggregation-related diseases.